Related references
Note: Only part of the references are listed.Update and new trends in antiemetic therapy: the continuing need for novel therapies
P. Feyer et al.
ANNALS OF ONCOLOGY (2011)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting
Thomas A. Burke et al.
SUPPORTIVE CARE IN CANCER (2011)
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
F. Roila et al.
ANNALS OF ONCOLOGY (2010)
Obstacles to the Implementation of Antiemetic Guidelines
Steven M. Grunberg
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Drug therapy: Chemotherapy-induced nausea and vomiting
Paul J. Hesketh
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiemetics: an update and the MASCC guidelines applied in clinical practice
Jorn Herrstedt
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre
A. Molassiotis et al.
SUPPORTIVE CARE IN CANCER (2008)
Chemotherapy-induced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings
Lorenzo Cohen et al.
SUPPORTIVE CARE IN CANCER (2007)
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment
Brigitte Bloechl-Daum et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting:: Pooled data from 2 randomised, double-blind, placebo controlled trials
DG Warr et al.
EUROPEAN JOURNAL OF CANCER (2005)
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
A Ihbe-Heffinger et al.
ANNALS OF ONCOLOGY (2004)
Chemotherapy-induced nausea and vomiting in routine practice:: a European perspective
A Glaus et al.
SUPPORTIVE CARE IN CANCER (2004)
Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions
F Roila
SUPPORTIVE CARE IN CANCER (2004)
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics - Perception versus reality
SM Grunberg et al.
CANCER (2004)
Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic prescribing guidelines
WC Mertens et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study
G Dranitsaris et al.
SUPPORTIVE CARE IN CANCER (2001)
Nausea and vomiting remain a significant clinical problem: Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices
JA Roscoe et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Share Paper
